Fresenius Kabi Contract Manufacturing

Fresenius Kabi Contract Manufacturing

Featured Exhibitors

Information

Fresenius Kabi Contract Manufacturing is a global CDMO specializing in sterile pharmaceutical development and manufacturing. With more than 50 years of experience and a worldwide network of manufacturing and R&D sites, we provide end-to-end solutions including formulation development, aseptic fill and finish, lyophilization, analytical testing, regulatory support, packaging, and global supply chain services. Our expertise in biologics, small molecules, and complex injectables helps pharmaceutical and biotech partners bring critical therapies to patients worldwide.
Exhibitor Type
Featured Exhibitor
Organization Type
Manufacturer/InnovatorContract ServiceCMO/CDMOPharmaceutical company
Country/Region
United States
Business Activity
API ProducerBiopharmaceuticalContract ManufacturerPharmaceutical Company (generic finished products)
Markets Active In
OceaniaNorth America (USA, Canada)AfricaMiddle East Region (e.g. UAE)Central America (e.g. Mexico)East Asia (e.g. China, Japan, Korea)Europe - EU countriesEurope - non EU (e.g. UK, Russia, ex-CIS countries)South America (e.g. Brazil, Colombia)South Asia (e.g. India, Pakistan, Sri Lanka)South East Asia (e.g. Thailand, Philippines, Singapore)
Products and Services
Biopharmaceutical ProductsContract Development and Manufacturing Organisations (CDMOs) and Contract Manufacturing Organisations (CMOs) (Services)Biopharmaceutical ServicesContract Packaging Services
Company Certification
OtherISOGMPCEFDA
Product Types
Biopharmaceutical Products
Service Types
Contract Development and Manufacturing Organisations (CDMOs) and Contract Manufacturing Organisations (CMOs) (Services)Biopharmaceutical ServicesContract Packaging Services
Service Categories
  • Biopharmaceutical Services
    • Contract Packaging Services
      • Aseptic Contract Manufacturing Services
        • Contract Manufacturing Services
          • Sterile Injectables Manufacturing Services

          Contact details

          https://cmo.fresenius-kabi.com
          United States

          Sessions

          From Innovation to Commercial Excellence: Tailored Manufacturing of Peptides and Beta-Lactam APIs in Europe.

          Wednesday, October 7, 2026 2:45 PM to 3:10 PM
          Manufacturing 5.0: Hall 10 - 10K69
          Antonio Ricci · Fresenius Kabi

          From Global to Local: Building Resilient Pharma Supply Chains Through Local-for-Local Manufacturing

          Thursday, October 8, 2026 11:30 AM to 11:55 AM
          Manufacturing 5.0: Hall 10 - 10K69
          Jennifer Dragan · Fresenius Kabi Global Alliance Management
          Philippe Drechsle

          Team

          Antonio Ricci
          Antonio Ricci
          Vice President R&D APIFresenius Kabi
          Jennifer Dragan
          Jennifer Dragan
          Director of Global Business DevelopmentFresenius Kabi Global Alliance Management
          Philippe Drechsle
          Philippe Drechsle
          Vice President, Commercial Product Strategy – Region Europe, International and APAC